CIK 0001534969
- Non-accelerated filer
- Smaller reporting company
- Emerging growth company
SERA PROGNOSTICS, INC.
Sign in to watch- Ticker
- SERA
- Exchange
- Nasdaq
- Industry
- Services-Medical Laboratories
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- Operating
- EIN
- 261911522
- Phone
- +1 801-990-0520
- Business address
- 2749 E. PARLEYS WAY, SUITE 200, SALT LAKE CITY, UT, 84109
- Former names
- SERA PROGNOSTICS, INC.
- 4 Open-market sale Chief Information Officer sold 645 shares at $3.13 ($2,019)
- 4 Open-market sale Chief Scientific Officer sold 1,395 shares at $3.13 ($4,366)
- 4 Open-market sale Chief Financial Officer sold 915 shares at $3.13 ($2,864)
- 4/A Planned sale Director sold 1,560 shares at $3.05 ($4,758)
- 4 Open-market sale Chief Executive Officer sold 21,158 shares at $3.15 ($66,648)
- 4 Open-market sale Chief Financial Officer sold 5,263 shares at $3.15 ($16,578)
- 4 Planned sale Director sold 3,899 shares at $3.05 ($11,892)
- 4 Planned sale Chief Information Officer sold 2,000 shares at $3.05 ($6,100)
- 4 Open-market sale Director sold 222 shares at $3.35 ($744)
- 4 Planned sale Chief Data Officer sold 1,458 shares at $3.49 ($5,088)
- 4 Planned sale Chief Data Officer sold 10,542 shares at $3.49 ($36,792)
- 4 Planned sale Chief Information Officer sold 6,000 shares at $2.22 ($13,320)
- 4 Open-market sale Chief Executive Officer sold 8,571 shares at $2.54 ($21,770)
- 4 Open-market sale Chief Data Officer sold 6,460 shares at $2.54 ($16,408)
- 4 Open-market sale General Counsel sold 6,447 shares at $2.54 ($16,375)
- 4 Open-market sale Chief Information Officer sold 5,962 shares at $2.54 ($15,143)
- 4 Open-market sale Chief Scientific Officer sold 7,094 shares at $2.54 ($18,019)
- 4 Open-market sale Chief Financial Officer sold 5,800 shares at $2.54 ($14,732)
- 4 Open-market sale Director sold 225 shares at $2.50 ($563)
- 4 Open-market sale Director sold 234 shares at $2.36 ($552)
Page 5 of 16 · 313 filings